These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Collagen VII Expression Is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes. Supp DM; Hahn JM; Combs KA; McFarland KL; Schwentker A; Boissy RE; Boyce ST; Powell HM; Lucky AW Cell Transplant; 2019; 28(9-10):1242-1256. PubMed ID: 31271052 [TBL] [Abstract][Full Text] [Related]
6. Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation. Ito K; Sawamura D; Goto M; Nakamura H; Nishie W; Sakai K; Natsuga K; Shinkuma S; Shibaki A; Uitto J; Denton CP; Nakajima O; Akiyama M; Shimizu H Am J Pathol; 2009 Dec; 175(6):2508-17. PubMed ID: 19893033 [TBL] [Abstract][Full Text] [Related]
7. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa. Kim M; Murrell DF Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672 [TBL] [Abstract][Full Text] [Related]
8. High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion. Pourreyron C; Chen M; McGrath JA; Salas-Alanis JC; South AP; Leigh IM Br J Dermatol; 2014 Jun; 170(6):1256-65. PubMed ID: 24641191 [TBL] [Abstract][Full Text] [Related]
9. A novel homozygous splice site mutation in COL7A1 in a Chinese patient with severe recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Huang L; Wong YP; Burd A Int J Dermatol; 2011 Jan; 50(1):52-6. PubMed ID: 21182502 [TBL] [Abstract][Full Text] [Related]
10. Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft. Iinuma S; Aikawa E; Tamai K; Fujita R; Kikuchi Y; Chino T; Kikuta J; McGrath JA; Uitto J; Ishii M; Iizuka H; Kaneda Y J Immunol; 2015 Feb; 194(4):1996-2003. PubMed ID: 25601922 [TBL] [Abstract][Full Text] [Related]
11. Histological and molecular restoration of type VII collagen in Recessive dystrophic epidermolysis bullosa mouse skin by topical injection of keratinocyte-like cells differentiated from human adipose-derived mesenchymal stromal cells. Matsuda A; Hasegawa T; Ikeda Y; Wada A; Ikeda S J Dermatol Sci; 2024 Jul; 115(1):42-50. PubMed ID: 38876908 [TBL] [Abstract][Full Text] [Related]
13. Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma. Atanasova VS; Pourreyron C; Farshchian M; Lawler M; Brown CA; Watt SA; Wright S; Warkala M; Guttmann-Gruber C; Hofbauer JP; Fuentes I; Prisco M; Rashidghamat E; Has C; Salas-Alanis JC; Palisson F; Hovnanian A; McGrath JA; Mellerio JE; Bauer JW; South AP Clin Cancer Res; 2019 Jun; 25(11):3384-3391. PubMed ID: 30846478 [TBL] [Abstract][Full Text] [Related]
14. Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development. Guerra L; Odorisio T; Zambruno G; Castiglia D Matrix Biol; 2017 Nov; 63():1-10. PubMed ID: 28126522 [TBL] [Abstract][Full Text] [Related]
15. Role of transforming growth factor-β1 in recessive dystrophic epidermolysis bullosa squamous cell carcinoma. Twaroski K; Chen W; Pickett-Leonard M; Tolar J Exp Dermatol; 2021 May; 30(5):664-675. PubMed ID: 33595864 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations. van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Ng YZ; Pourreyron C; Salas-Alanis JC; Dayal JH; Cepeda-Valdes R; Yan W; Wright S; Chen M; Fine JD; Hogg FJ; McGrath JA; Murrell DF; Leigh IM; Lane EB; South AP Cancer Res; 2012 Jul; 72(14):3522-34. PubMed ID: 22564523 [TBL] [Abstract][Full Text] [Related]
18. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa. Rokunohe A; Nakano H; Aizu T; Kaneko T; Nakajima K; Ikenaga S; Matsuzaki Y; Murai T; Tamai K; Sawamura D J Dermatol; 2008 Jun; 35(6):336-40. PubMed ID: 18578710 [TBL] [Abstract][Full Text] [Related]
19. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita. Watanabe M; Natsuga K; Shinkuma S; Shimizu H J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483 [TBL] [Abstract][Full Text] [Related]
20. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]